DAT Genotype Modulates Brain and Behavioral Responses Elicited by Cigarette Cues

We previously demonstrated differential activation of the mesocorticolimbic reward circuitry in response to cigarette cues independent of withdrawal. Despite robust effects, we noted considerable individual variability in brain and subjective responses. As dopamine (DA) is critical for reward and its predictive signals, genetically driven variation in DA transmission may account for the observed differences. Evidence suggests that a variable number of tandem repeats (VNTRs) polymorphism in the DA transporter (DAT) SLC6A3 gene may influence DA transport. Brain and behavioral responses may be enhanced in probands carrying the 9-repeat allele. To test this hypothesis, perfusion fMR images were acquired during cue exposure in 19 smokers genotyped for the 40 bp VNTR polymorphism in the SLC6A3 gene. Contrasts between groups revealed that 9-repeat (9-repeats) had a greater response to smoking (vs nonsmoking) cues than smokers homozygous for the 10-repeat allele (10/10-repeats) bilaterally in the interconnected ventral striatal/pallidal/orbitofrontal cortex regions (VS/VP/OFC). Activity was increased in 9-repeats and decreased in 10/10-repeats in the VS/VP/OFC (p<0.001 for all analyses). Brain activity and craving was strongly correlated in 10/10-repeats in these regions and others (anterior cingulate, parahippocampal gyrus, and insula; r2=0.79–0.86, p<0.001 in all regions). Alternatively, there were no significant correlations between brain and behavior in 9-repeats. There were no differences in cigarette dependence, demographics, or resting baseline neural activity between groups. These results provide evidence that genetic variation in the DAT gene contributes to the neural and behavioral responses elicited by smoking cues.

[1]  John Listerud,et al.  Prelude to Passion: Limbic Activation by “Unseen” Drug and Sexual Cues , 2008, PloS one.

[2]  M. Caron,et al.  The dopamine transporter: A crucial component regulating dopamine transmission , 1997, Movement disorders : official journal of the Movement Disorder Society.

[3]  Donald S. Williams,et al.  Perfusion imaging , 1992, Magnetic resonance in medicine.

[4]  G Di Chiara,et al.  Role of dopamine in the behavioural actions of nicotine related to addiction. , 2000, European journal of pharmacology.

[5]  W. Goodman,et al.  Disgust and the insula: fMRI responses to pictures of mutilation and contamination , 2004, Neuroreport.

[6]  Alan C. Evans,et al.  Changes in brain activity related to eating chocolate: from pleasure to aversion. , 2001, Brain : a journal of neurology.

[7]  R P Mattick,et al.  Quitting smoking: estimation by meta-analysis of the rate of unaided smoking cessation. , 2010, Australian journal of public health.

[8]  Karl Fagerstrom,et al.  Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire , 1989, Journal of Behavioral Medicine.

[9]  M. G. Haviland,et al.  An observer scale to measure alexithymia. , 2000, Psychosomatics.

[10]  John A Detre,et al.  Perfusion fMRI for functional neuroimaging. , 2005, International review of neurobiology.

[11]  J. Gelernter,et al.  Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF)). , 1998, Genomics.

[12]  Clinton D Kilts,et al.  The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density , 2005, BMC Genetics.

[13]  Monique Ernst,et al.  Increased Occupancy of Dopamine Receptors in Human Striatum during Cue-Elicited Cocaine Craving , 2006, Neuropsychopharmacology.

[14]  Wolf-Dieter Heiss,et al.  Differente Muster regionaler Hirnaktivitat nach emotionaler Stimulation bei alexithymen Patienten im Vergleich zu Normalpersonen. Eine Positronen-Emissions-Tomographische (PET) Studie mit 150-H2O und emotionaler Stimulierung durch autobiographische Erinnerung. , 2002 .

[15]  A. Dagher,et al.  Conditioned Dopamine Release in Humans: A Positron Emission Tomography [11C]Raclopride Study with Amphetamine , 2007, The Journal of Neuroscience.

[16]  Marc Laruelle,et al.  Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  Wei Zhu,et al.  Exposure to appetitive food stimuli markedly activates the human brain , 2004, NeuroImage.

[18]  Kenneth K Kidd,et al.  Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles , 1999, Biological Psychiatry.

[19]  I. Craig,et al.  Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. , 2002, American journal of medical genetics.

[20]  Marc Laruelle,et al.  The Variable Number of Tandem Repeats Polymorphism of the Dopamine Transporter Gene Is Not Associated with Significant Change in Dopamine Transporter Phenotype in Humans , 2001, Neuropsychopharmacology.

[21]  C. Duvauchelle,et al.  Conditioned increases in behavioral activity and accumbens dopamine levels produced by intravenous cocaine. , 2000, Behavioral neuroscience.

[22]  K. Hutchison,et al.  The DRD4 VNTR polymorphism influences reactivity to smoking cues. , 2002, Journal of abnormal psychology.

[23]  J. Gläscher,et al.  Gene–gene interaction associated with neural reward sensitivity , 2007, Proceedings of the National Academy of Sciences.

[24]  F. Joseph McClernon,et al.  DRD4 VNTR polymorphism is associated with transient fMRI-BOLD responses to smoking cues , 2007, Psychopharmacology.

[25]  J. Poline,et al.  Effect of impaired recognition and expression of emotions on frontocingulate cortices: an fMRI study of men with alexithymia. , 2002, The American journal of psychiatry.

[26]  A. Heath,et al.  Genetic Influences on Smoking Behavior , 1995 .

[27]  S. Shiffman,et al.  A meta-analysis of the efficacy of over-the-counter nicotine replacement , 2003, Tobacco control.

[28]  D. Mash,et al.  Dopamine transport function is elevated in cocaine users , 2002, Journal of neurochemistry.

[29]  S. Fuke,et al.  The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression , 2001, The Pharmacogenomics Journal.

[30]  W. Alvarez,et al.  Alexithymia and posttraumatic stress disorder. , 1991, The Journal of clinical psychiatry.

[31]  R. Stark,et al.  The insula is not specifically involved in disgust processing: an fMRI study , 2002, Neuroreport.

[32]  X Li,et al.  Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. , 1992, Genomics.

[33]  Joseph J Paton,et al.  Flexible Neural Representations of Value in the Primate Brain , 2007, Annals of the New York Academy of Sciences.

[34]  S. Shiffman,et al.  First lapses to smoking: within-subjects analysis of real-time reports. , 1996, Journal of consulting and clinical psychology.

[35]  R. Wightman,et al.  Rapid Dopamine Signaling in the Nucleus Accumbens during Contingent and Noncontingent Cocaine Administration , 2005, Neuropsychopharmacology.

[36]  Ze Wang,et al.  Empirical optimization of ASL data analysis using an ASL data processing toolbox: ASLtbx. , 2008, Magnetic resonance imaging.

[37]  H. Duvernoy The Human Brain , 1999, Springer Vienna.

[38]  R. Wise,et al.  Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[39]  Alain Dagher,et al.  Effects of Expectancy and Abstinence on the Neural Response to Smoking Cues in Cigarette Smokers: an fMRI Study , 2006, Neuropsychopharmacology.

[40]  R. Bagby,et al.  A preliminary investigation of alexithymia in men with psychoactive substance dependence. , 1990, The American journal of psychiatry.

[41]  R. Ehrman,et al.  Effect of smoking cues and cigarette availability on craving and smoking behavior. , 1995, Addictive behaviors.

[42]  J. E. Sherman,et al.  The motivation to use drugs: a psychobiological analysis of urges. , 1986, Nebraska Symposium on Motivation. Nebraska Symposium on Motivation.

[43]  D. Comings,et al.  The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. , 1996, Pharmacogenetics.

[44]  Chronic Disease Division Cancer facts and figures , 2010 .

[45]  M. Taylor Comments on task force report on psychiatric residency. , 1990, The American journal of psychiatry.

[46]  K. Franklin,et al.  The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine , 2005, Psychopharmacology.

[47]  Karl Herholz,et al.  [Different patterns of regional brain activation during emotional stimulation in alexithymics in comparison with normal controls]. , 2002, Psychotherapie, Psychosomatik, medizinische Psychologie.

[48]  D. Weinberger,et al.  Imaging Genetics: Perspectives from Studies of Genetically Driven Variation in Serotonin Function and Corticolimbic Affective Processing , 2006, Biological Psychiatry.

[49]  F. Pontieri,et al.  Functional correlates of nicotine administration: similarity with drugs of abuse , 1998, Journal of Molecular Medicine.

[50]  R. Ehrman,et al.  Limbic Activation to Cigarette Smoking Cues Independent of Nicotine Withdrawal: A Perfusion fMRI Study , 2007, Neuropsychopharmacology.

[51]  Hasse Karlsson,et al.  Cortical activation in alexithymia as a response to emotional stimuli , 2008, British Journal of Psychiatry.

[52]  C. Blaha,et al.  The relation between dopamine oxidation currents in the nucleus accumbens and conditioned increases in motor activity in rats following repeated administration of d‐amphetamine or cocaine , 1998, The European journal of neuroscience.

[53]  Axel Schäfer,et al.  Stimulus type and design influence hemodynamic responses towards visual disgust and fear elicitors. , 2005, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[54]  J. Hughes,et al.  Effects of abstinence from tobacco: valid symptoms and time course. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[55]  M. Reivich,et al.  Limbic activation during cue-induced cocaine craving. , 1999, The American journal of psychiatry.

[56]  J. Parkinson,et al.  Neural contributions to the motivational control of appetite in humans , 2004, The European journal of neuroscience.

[57]  J. Nurnberger,et al.  A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. , 1991, Nucleic acids research.

[58]  Karl J. Friston,et al.  Mixtures of general linear models for functional neuroimaging , 2003, IEEE Transactions on Medical Imaging.

[59]  T. Robbins,et al.  Nucleus accumbens dopamine depletion impairs both acquisition and performance of appetitive Pavlovian approach behaviour: implications for mesoaccumbens dopamine function , 2002, Behavioural Brain Research.

[60]  S. S. St. Jeor,et al.  D2 dopamine receptor gene and cigarette smoking: a reward gene? , 1994, Medical hypotheses.

[61]  Cigarette smoking-attributable mortality and years of potential life lost--United States, 1990. , 1993, MMWR. Morbidity and mortality weekly report.

[62]  Bertram Walter,et al.  Hemodynamic brain correlates of disgust and fear ratings , 2007, NeuroImage.

[63]  John A Detre,et al.  Precision of the CASL‐perfusion MRI technique for the measurement of cerebral blood flow in whole brain and vascular territories , 2003, Journal of magnetic resonance imaging : JMRI.

[64]  L. Kozlowski,et al.  Smoking status and the human dopamine transporter variable number of tandem repeats (VNTR) polymorphism: failure to replicate and finding that never-smokers may be different. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[65]  A. Sorkin,et al.  Rapid regulation of the dopamine transporter: role in stimulant addiction? , 2004, Neuropharmacology.

[66]  Jiro Gyoba,et al.  Specific brain processing of facial expressions in people with alexithymia: an H2 15O-PET study. , 2003, Brain : a journal of neurology.

[67]  Edythe D London,et al.  Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. , 2006, Archives of general psychiatry.

[68]  G. Chiara,et al.  Drug Addiction as a Disorder of Associative Learning: Role of Nucleus Accumbens Shell/Extended Amygdala Dopamine , 1999, Annals of the New York Academy of Sciences.

[69]  Brian Knutson,et al.  Incentive-Elicited Brain Activation in Adolescents: Similarities and Differences from Young Adults , 2004, The Journal of Neuroscience.

[70]  C. Lerman,et al.  Effects of dopamine D2 receptor (DRD2) and transporter (SLC6A3) polymorphisms on smoking cue-induced cigarette craving among African-American smokers , 2005, Molecular Psychiatry.

[71]  T. Franklin,et al.  Involvement of the Nucleus Accumbens and Medial Prefrontal Cortex in the Expression of Conditioned Hyperactivity to a Cocaine-Associated Environment in Rats , 2000, Neuropsychopharmacology.

[72]  N. Noviello,et al.  Towards a teleological model of alexithymia: alexithymia and post-traumatic stress disorder. , 1983, Psychotherapy and psychosomatics.

[73]  T. Franklin,et al.  Expression of Fos‐related antigens in the nucleus accumbens and associated regions following exposure to a cocaine‐paired environment , 2000, The European journal of neuroscience.

[74]  Douglas W. Jones,et al.  Genotype Influences In Vivo Dopamine Transporter Availability in Human Striatum , 2000, Neuropsychopharmacology.

[75]  M. Benwell,et al.  The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence , 2000, Behavioural Brain Research.

[76]  J. Detre,et al.  Technical aspects and utility of fMRI using BOLD and ASL , 2002, Clinical Neurophysiology.

[77]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[78]  C. Morris,et al.  Lack of association between the dopamine D2 receptor gene allele DRD2*A1 and cigarette smoking in a United Kingdom population. , 1998, Pharmacogenetics.

[79]  L. Bierut,et al.  Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking. , 2000, American journal of medical genetics.

[80]  G. Di Chiara,et al.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[81]  W. Berrettini,et al.  The genetic determinants of smoking. , 2003, Chest.

[82]  N. Volkow,et al.  Cocaine Cues and Dopamine in Dorsal Striatum: Mechanism of Craving in Cocaine Addiction , 2006, The Journal of Neuroscience.